Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: Analysis of women in the control arm of the randomized, controlled PATRICIA trial

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Castellsagué, Xavier ^a   Paavonen, Jorma ^b   Jaisamrarn, Unnop ^c   Wheeler, Cosette M ^d   Skinner, S Rachel ^e,y   Lehtinen, Matti ^f,v   Naud, Paulo ^g   Chow, Song Nan ^h   Del Rosario Raymundo, Maria Rowena ^i,v   Teixeira, Julio C ^j   Palmroth, Johanna ^k   De Carvalho, Newton S ^l,v   Germar, Maria Julieta V ^m,v   Peters, Klaus ⁿ   Garland, Suzanne M ^o,v,z,aa,ab   Szarewski, Anne ^p   Poppe, Willy A J ^q   Romanowski, Barbara ^r   Schwarz, Tino F ^s   Tjalma, Wiebren A A ^t   Bosch, F Xavier ^a,u   Bozonnat, Marie Cecile ^v   Struyf, Frank ^w   Dubin, Gary ^x   Rosillon, Dominique ^w   Baril, Laurence ^w   Denham, I ^v   Mindel, A ^v   De Sutter, P ^v   Aoki, F Y ^v   Diaz Mitoma, F ^v   Dionne, M ^v   Ferguson, L ^v   Miller, M ^v   Papp, K ^v   Ramjattan, B ^v   Orr, P H ^v   Somani, R ^v   Apter, D ^v   Karppa, T ^v   Kudjoi, N ^v   Kyha osterlund L ^v   Lonnberg K ^v   Lunnas, T ^v   Petaja, T ^v   Vilkki, M ^v   Gent, T ^v   Grubert, T ^v   D Hopker W ^v   Schulze, K ^v   Salmeron J ^v   Crisostomo, C ^v   Raymundo, J E ^v   Limson, G ^v   Remollino, C ^v   Villanueva, G ^v   Villanueva, S ^v   Zamora, J D ^v   Bajo Arenas, J ^v   Bayas, J ^v   Campins, M ^v   Castro, M ^v   Centeno, C ^v   Rodriguez de la Pinta M L ^v   Torne A ^v   Vidart, J A ^v   Yu, M H ^v   Angsuwathana, S ^v   Cruickshank, M ^v   A Hakim, E ^v   Kitchener, H ^v   Lewis, D ^v   Ackerman, R ^v   Caldwell, M ^v   Chambers, C ^v   Chatterjee, A ^v   DeMars, L ^v   Downs, L ^v   Ferris, D ^v   Fine, P ^v   Hedrick, J ^v   Huh, W ^v   Klein, T ^v   Lalezari, J ^v   Luber, S ^v   Martens, M ^v   Peterson, C ^v   Rosen, J ^v   Seidman, L ^v   Sperling, M ^v   Sperling, R ^v   Stager, M ^v   Stapleton, J ^v   Swenson, K ^v   Thoming, C ^v   Twiggs, L ^v   Waldbaum, A ^v   more..

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF HELSINKI   (Finland)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f UNIVERSITY OF TAMPERE   (Finland)

^g HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^h NATIONAL TAIWAN UNIVERSITY   (Taiwan)

ⁱ San Pablo Colleges Medical Center   (Philippines)

^j UNIVERSITY OF CAMPINAS   (Brazil)

^k North Carelian Polytechnic   (Finland)

^l FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^m UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

ⁿ Facharzt für Frauenheilkunde und Geburtshilfe   (Germany)

^o ROYAL WOMEN'S HOSPITAL   (Australia)

^p QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^q UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^r UNIVERSITY OF ALBERTA   (Canada)

^s UNIVERSITY OF WÜRZBURG   (Germany)

^t ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^u Network on Cooperative Cancer Research RTICC   (Spain)

^v 4Clinics ^*  (United States)

^w GSK   (Belgium)

^x GLAXOSMITHKLINE   (United States)

^y UNIVERSITY OF SYDNEY   (Australia)

^z ROYAL CHILDREN'S HOSPITAL   (Australia)

^aa MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^ab UNIVERSITY OF MELBOURNE   (Australia)

more..

Author keywords

CIN; HPV; Risk; Sexual intercourse; Time

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIASIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 34; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 40; HUMAN PAPILLOMAVIRUS TYPE 42; HUMAN PAPILLOMAVIRUS TYPE 43; HUMAN PAPILLOMAVIRUS TYPE 44; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 54; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 70; HUMAN PAPILLOMAVIRUS TYPE 74; INCIDENCE; INFECTION RISK; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALITY; SINGLE (MARITAL STATUS); TOBACCO USE; TREATMENT DURATION; UNIVARIATE ANALYSIS; UTERINE CERVIX CARCINOMA IN SITU; CERVICAL INTRAEPITHELIAL NEOPLASIA; PAPILLOMAVIRUS INFECTIONS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SPAIN; STATISTICS AND NUMERICAL DATA; TIME; UTERINE CERVICAL NEOPLASMS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED, 80 AND OVER; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; INCIDENCE; PAPILLOMAVIRUS INFECTIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SEXUAL BEHAVIOR; SEXUAL PARTNERS; SPAIN; TIME FACTORS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84964316120     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-014-0551-y     Document Type: Article

References (28)

1. World Health Organization: Human papillomavirus laboratory manual. First edition. In 2009 [http://www.who.int/immunization/documents/WHO_IVB_10.12/en/]
2. Koshiol J, Lindsey L, Pimenta JM, Poole C, Jenkins D, Smith JS: Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol 2008, 168:123-137.
3. Woodman CBJ, Collins S, Winter H, Bailey A, Ellis J, Prior P, Yates M, Rollason TP, Young LS: Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001, 357:1831-1836.
4. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
5. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME, Kurman RJ, Manos MM: Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994, 169:235-240.
6. International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P, Beral V, de Berrington González A, Colin D, Franceschi S, Goodill A, Green J, Peto J, Plummer M, Sweetland S: Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13, 541 women with carcinoma of the cervix and 23, 017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 2006, 118:1481-1495.
7. International Collaboration of Epidemiological Studies of Cervical Cancer: Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8, 097 women with squamous cell carcinoma and 1, 374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer 2006, 120:885-891.
8. International Collaboration of Epidemiological Studies of Cervical Cancer: Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15, 461 women with cervical carcinoma and 29, 164 women without cervical carcinoma from 21 epidemiological studies. Cancer Epidemiol Biomarkers Prev 2009, 18:1060-1069.
9. Smith JS, Muñoz N, Herrero R, Eluf-Neto J, Ngelangel C, Franceschi S, Bosch FX, Walboomers JM, Peeling RW: Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 2002, 185:324-331.
10. Silins I, Ryd W, Strand A, Wadell G, Törnberg S, Hansson BG, Wang X, Arnheim L, Dahl V, Bremell D, Persson K, Dillner J, Rylander E: Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer 2005, 116:110-115.
11. Wallin KL, Wiklund F, Luostarinen T, Angström T, Anttila T, Bergman F, Hallmans G, Ikäheimo I, Koskela P, Lehtinen M, Stendahl U, Paavonen J, Dillner J: A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma. Int J Cancer 2002, 101:371-374.
12. Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, Tu W, Juliar BE, Breen TE, Fortenberry JD: A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 2005, 191:182-192.
13. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA: Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003, 157:218-226.
14. Collins S, Mazloomzadeh S, Winter H, Blomfield P, Bailey A, Young LS, Woodman CB: High incidence of cervical human papillomavirus infection in women during their first sexual relationship. BJOG 2002, 109:96-98.
15. Kjaer SK, Chackerian B, van den Brule AJ, Svare EI, Paull G, Walbomers JM, Schiller JT, Bock JE, Sherman ME, Lowy DR, Meijer CL: High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev 2001, 10:101-106.
16. Rodriguez AC, Burk R, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillen D, Alfaro M, Viscidi R, Morales J, Hutchinson M, Wacholder S, Schiffman M: The natural history of human papillomavirus infection and cervical intraepithelial neoplasia among young women in the Guanacaste cohort shortly after initiation of sexual life. Sex Transm Dis 2007, 34:494-502.
17. Jaisamrarn U, Castellsagué X, Garland SM, Naud P, Palmroth J, Del Rosario-RaymundoMR, Wheeler CM, Salmerón J, Chow S-N, Apter D, Teixeira JC, Skinner SR, Hedrick J, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WAJ, Bosch FX, de Carvalho NS, Germar MJ, Peters K, Paavonen J, Bozonnat M-C, Descamps D, Struyf F, Dubin GO, Rosillon D, Baril L, for the HPV PATRICIA Study Group: Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study. PLoS One 2013, doi:10.1371/annotation/cea59317-929c-464a-b3f7-e095248f229a.
18. Paavonen J, Jenkins D, Bosch FX, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter DL, Kitchener HC, Castellsague X, de Carvalho NS, Skinner SR, Harper DM, Hedrick JA, Jaisamrarn U, Limson GA, Dionne M, Quint W, Spiessens B, Peeters P, Struyf F, Wieting SL, Lehtinen MO, Dubin G, HPV PATRICIA study group: Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 2007, 369:2161-2170.
19. Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, Hedrick J, Jaisamrarn U, Limson G, Garland S, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Jenkins D, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G, HPV PATRICIA Study Group: Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009, 374:301-314.
20. Lehtinen M, Apter D, Dubin G, Kosunen E, Isaksson R, Korpivaara EL, Kyhä-Osterlund L, Lunnas T, Luostarinen T, Niemi L, Palmroth J, Petäjä T, Rekonen S, Salmivesi S, Siitari-Mattila M, Svartsjö S, Tuomivaara L, Vilkki M, Pukkala E, Paavonen J: Enrolment of 22, 000 adolescent women to cancer registry follow-up for long-term human papillomavirus vaccine efficacy: guarding against guessing. Int J STD AIDS 2006, 17:517-521.
21. van Doorn L-J, Molijn A, Kleter B, Quint W, Colau B: Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR. J Clin Microbiol 2006, 44:3292-3298.
22. Roset Bahmanyar E, Paavonen J, Naud P, Salmerón J, Chow SN, Apter D, Kitchener H, Castellsagué X, Teixeira JC, Skinner SR, Jaisamrarn U, Limson GA, Garland SM, Szarewski A, Romanowski B, Aoki F, Schwarz TF, Poppe WA, De Carvalho NS, Harper DM, Bosch FX, Raillard A, Descamps D, Struyf F, Lehtinen M, Dubin G, HPV PATRICIA Study Group: Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women enrolled in the multinational PATRICIA trial. Gynecol Oncol 2012, 127:440-450.
23. Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S: Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 2010, 202:1789-1799.
24. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK, Muñoz N: Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 2008, 26(Suppl 10):K1-K16.
25. Wheeler CM, Hunt WC, Schiffman M, Castle PE, Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study Group: Human papillomavirus genotypes and the cumulative risk of cervical precancer. J Infect Dis 2006, 194:1291-1299.
26. Liaw KL, Hildesheim A, Burk RD, Gravitt P, Wacholder S, Manos MM, Scott DR, Sherman ME, Kurman RJ, Glass AG, Anderson SM, Schiffman M: A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 2001, 183:8-15.
27. Mendez F, Munoz N, Posso H, Molano M, Moreno V, van den Brule AJ, Ronderos M, Meijer C, Munoz A, Instituto Nacional de Cancerologia Human Papillomavirus Study Group: Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J Infect Dis 2005, 192:1158-1165.
28. Rousseau MC, Pereira JS, Prado JC, Villa LL, Rohan TE, Franco EL: Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. J Infect Dis 2001, 184:1508-1517.